Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for advanced non-small cell lung cancer patients with high PD-L1 tumor expression receiving pembrolizumab

BACKGROUND: We investigated the association of peripheral blood inflammatory markers with overall survival (OS) in pembrolizumab treated advanced non-small cell lung cancer (aNSCLC) patients with programmed death ligand 1 (PD-L1) expression ≥50%. Clinical risk factors for development of immune-relat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Lung Cancer Res
Main Authors: Ksienski, Doran, Wai, Elaine S., Alex, Deepu, Croteau, Nicole S., Freeman, Ashley T., Chan, Angela, Patterson, Tiffany, Clarkson, Melissa, Fiorino, Leathia, Poonja, Zia, Fenton, David, Irons, Sarah, Lesperance, Mary
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7867765/
https://ncbi.nlm.nih.gov/pubmed/33569318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-541
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados